Press release
Global Insulin Delivery Devices Market Set to Surpass US$ 33.1 Billion by 2033 Amid Rising Diabetes Burden and Technological Advancements
The global insulin delivery devices market is poised for robust growth, projected to double its valuation from 2023 to 2033. With a compound annual growth rate (CAGR) of 7%, the market is expanding steadily, driven by rising diabetes prevalence, the growing aging population, and increasing awareness about personalized healthcare and home-based diabetes management.As of 2023, the market is valued at approximately US$ 16.8 billion, with expectations to exceed US$ 33.1 billion by 2033. This surge is largely attributed to the global uptick in diabetes cases, triggered by sedentary lifestyles, unhealthy diets, and increasing obesity rates.
Browse Full Report: https://www.factmr.com/report/5105/insulin-delivery-devices-market
Key Growth Drivers
1. Rising Diabetes Incidence: Globally, diabetes is becoming more prevalent, particularly Type 2 diabetes. This chronic condition necessitates frequent and reliable insulin administration, fueling demand for user-friendly delivery solutions.
2. Advances in Device Technology: Innovations such as smart insulin pens, connected pumps, and wearable insulin injectors are enhancing ease-of-use and real-time glucose monitoring for patients.
3. Aging Population: Countries like Japan and Germany, with high proportions of elderly citizens, are seeing growing adoption of insulin delivery systems tailored for senior patients.
4. Home-based Care Adoption: A surge in remote health monitoring and home care practices has amplified the need for portable and automated insulin delivery options.
Competitive Landscape: Major Players & Innovations
The insulin delivery devices market is highly competitive, featuring prominent players like Medtronic plc, Novo Nordisk A/S, Eli Lilly and Company, Sanofi S.A., F. Hoffmann-La Roche Ltd., Becton, Dickinson and Company, and Tandem Diabetes Care Inc.
Recent strategic moves shaping the market include:
Tandem Diabetes Care's acquisition of AMF Medical (Switzerland) in December 2022 for US$ 216 million. This acquisition enhanced Tandem's wearable device portfolio and next-gen insulin management capabilities.
MannKind Corporation's acquisition of V-Go insulin delivery technology from Zealand Pharma for US$ 10 million in May 2022. This move broadened MannKind's offering for type 2 diabetic patients in need of flexible insulin solutions.
Novo Nordisk's launch of smart insulin pens-NovoPen 6 and NovoPen Echo Plus-in the UK, giving patients access to digital tools that log insulin dosing information automatically.
Emerging startups are also entering the space with AI-integrated insulin delivery systems. Notably, Diabeloop, a French med-tech startup, raised US$ 75 million in a Series C round in 2022 to commercialize AI-powered diabetes solutions globally.
For More Insights into the Market, Request a Sample of this Report:
https://www.factmr.com/connectus/sample?flag=S&rep_id=5105
Regional Insights
1. North America: Holds the largest share (~36%) owing to a well-established healthcare system, favorable reimbursement policies, and a high diabetic population.
2. Europe: Led by Germany, the region is witnessing rapid growth due to obesity-related diabetes cases and rising government investments in healthcare.
3. Asia Pacific: Japan and China are seeing a sharp rise in demand due to increased elderly population and improved awareness about diabetes treatment options.
Japan's aging population offers a particularly attractive opportunity, with nearly one-third of citizens above 60-leading to increased demand for medical devices including insulin injectors, pens, and pumps.
Segment Insights
Insulin pens dominate the market, accounting for around 35% of the share in 2023. Their popularity stems from ease of use, portability, and growing adoption among elderly and pediatric patients. Reusable insulin pens are gaining traction in cost-sensitive markets, while wearable insulin devices are rapidly emerging as a global trend.
Challenges
Despite favorable growth prospects, market development faces hurdles including:
1. High cost of advanced devices making accessibility difficult in low- and middle-income regions.
2. Frequent product recalls, which affect consumer trust and create regulatory pressures.
3. Cybersecurity risks tied to connected devices, such as insulin pumps, have raised concerns around unauthorized access and patient safety.
As diabetes prevalence continues to climb globally, the insulin delivery devices market is primed for strong growth, innovation, and investment. With major players focusing on smart, connected, and patient-friendly devices, the landscape is shifting rapidly towards personalized, data-driven care models. Ongoing R&D efforts, emerging startup innovations, and strategic collaborations are expected to define the next decade of diabetes management solutions.
Check out More Related Studies Published by Fact.MR:
Adult Cardiovascular Surgical Instruments Package Market
https://www.factmr.com/report/2684/adult-cardiovascular-surgical-instruments-package-market
Optic Nerve Disorders Drugs Market
https://www.factmr.com/report/2689/optic-nerve-disorders-drugs-market
Nucleic Acid Arrays Market
https://www.factmr.com/report/2695/nucleic-acid-arrays-market
Microplate Washer Market
https://www.factmr.com/report/2700/microplate-washer-market
Contact:
US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583, +353-1-4434-232
Email: sales@factmr.com
About Fact.MR
We are a trusted research partner of 80% of fortune 1000 companies across the globe. We are consistently growing in the field of market research with more than 1000 reports published every year. The dedicated team of 400-plus analysts and consultants is committed to achieving the utmost level of our client's satisfaction.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Insulin Delivery Devices Market Set to Surpass US$ 33.1 Billion by 2033 Amid Rising Diabetes Burden and Technological Advancements here
News-ID: 4115781 • Views: …
More Releases from Fact.MR

Bioinformatics Market is Growing at a CAGR of 13.4% by 2034 | Fact.MR Report
The latest report on the Bioinformatics Market, projecting robust growth driven by the increasing demand for genomic research, advancements in artificial intelligence (AI), and the rising adoption of precision medicine. Valued at USD 14.29 billion in 2024, the global market is forecast to expand at a compound annual growth rate (CAGR) of 13.4%, reaching USD 50.25 billion by 2034. This significant growth underscores the critical role of bioinformatics in decoding…

Residential Robotic Vacuum Cleaner Market to Reach USD 11.6 Billion by 2033 | Ke …
Fact.MR today released its latest report on the Residential Robotic Vacuum Cleaner Market, projecting robust growth driven by increasing demand for automation, busy lifestyles, and advancements in smart home technologies. Valued at USD 3.0 billion in 2023, the global market is forecast to expand at a compound annual growth rate (CAGR) of 14.4%, reaching USD 11.6 billion by 2033. This significant growth highlights the rising adoption of robotic vacuum cleaners…

Brain-Computer Interface Market is Estimated to Reach USD 6.5 Billion by 2033
The global brain-computer interface (BCI) market was valued at USD 1.6 billion in 2022 and is projected to reach USD 6.5 billion by 2033, growing at a compound annual growth rate (CAGR) of 13.6% from 2023 to 2033. This expansion reflects the increasing adoption of BCI technologies in medical applications, driven by advancements in neuroscience, AI, and sensor technologies. BCIs enable direct communication between the brain and external devices, offering…

Orally Disintegrating Tablet Market is Projected to Reach USD 72.68 Billion by 2 …
The global orally disintegrating tablet (ODT) market is valued at USD 24.45 billion in 2024 and is forecasted to expand at a compound annual growth rate (CAGR) of 11.5%, reaching USD 72.68 billion by 2034. This robust growth is driven by the increasing demand for patient-friendly dosage forms, particularly among the elderly, pediatric, and dysphagic populations, who benefit from ODTs' ease of administration without water and rapid dissolution. ODTs enhance…
More Releases for Device
Medical Device Regulatory Affairs Market Medical Device Regulatory Affairs Marke …
"Medical Device Regulatory Affairs Market" in terms of revenue was estimated to be worth $ 6.7 billion in 2024 and is poised to reach $ 18.3 billion by 2034, growing at a CAGR of 10.8% from 2025 to 2034 according to a new report by InsightAce Analytic.
Request For Free Sample Pages:
https://www.insightaceanalytic.com/request-sample/1913
Latest Drivers Restraint and Opportunities Market Snapshot:
Key factors influencing the global medical device regulatory…
Surge In Wireless Device Usage Boosts Wireless Audio Device Market Driving Marke …
Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.
How Large Will the Wireless Audio Device Market Size By 2025?
In recent years, there has been remarkable growth in the wireless audio device market size. The market, which is projected to expand from $41.85 billion in 2024 to $52.37 billion in 2025, boasts a compound annual growth rate (CAGR) of 25.1%. Factors contributing…
Anti-snoring Device Market - Quiet Nights, Restful Sleep: Anti-snoring Device In …
Newark, New Castle, USA: The "Anti-snoring Device Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Anti-snoring Device Market: https://www.growthplusreports.com/report/antisnoring-device-market/8931
This latest report researches the industry structure, sales, revenue,…
Global Watch Clock Measuring Device Market | Watch Clock Measuring Device Indust …
Watch, clock and measuring device market comprises of the sales of watch, clock, measuring device & related services to measure the time and physical quantity. Watch is portable timepiece, which is worn by people around the wrist, attached by a strap. Clock is a device used to measure and indicate time, using the pointers moving over a dial. Measuring device is an instrument used for measuring the various parameters in…
Peripheral Vascular Device Market Size, Peripheral Vascular Device Market Share, …
Global Peripheral Vascular Device Market Size is observed to gain traction owing to the factors such as increasing research and development for developing several new product, and rising funding by the private organizations.
Request for Sample of This Research Report @ https://bit.ly/2xjOKpC
Top Key Player:-
Abbott Laboratories
Braun Melsungen AG
Boston Scientific Corporation
R. Brad, Inc.
Cardinal Health, Inc.
Medtronic plc.
Cook Medical, Inc.
Teruma Corporation
Jude Medical, Inc.
The Spectranetics Corporation
Volcano Corporation
Peripheral vascular disorder (PVD) is a blood circulation disorder…
Medical Device Technologies Market - The Evolution of Medical Device Technologie …
The global medical device technologies market is anticipated to be boosted by various well-known players in the market. Some of these players that are dealing with the manufacturing of in vitro diagnostic devices hold a significant share in the global market. Whereas, the small market players are emerging from several developing nations, looking to set their foot in the market. Such measures are foreseen to change the market scenario in…